An Observational Study of Patients With Metabolic Syndrome and Related Conditions
NCT ID: NCT05842811
Last Updated: 2023-05-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
2000000 participants
OBSERVATIONAL
2023-05-24
2038-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Metabolic Indicator Study
NCT03588117
Cardiovascular Risk Evaluation in Clinical Practice in Metabolic Syndrome Patients
NCT00171548
Design of a Genetic Score to Predict the Response to a Dietary Intervention in Adults With Metabolic Syndrome
NCT05495074
Regional Observation of the Metabolic Syndrome
NCT00874952
Personalized Nutrition Prediction for Metabolic Syndrome Patients, an Open Single-center Study
NCT03058016
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Disease Cohort
Observational
No interventions assigned to this group
Engaged Cohort
Observational
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adult patients diagnosed and managed for these conditions invited to participate
* Ability to provide written informed consent
Exclusion Criteria
* Manual removal (sponsor or site request)
* No EHR interface encounter \> 3 years
Engaged Cohort
* Patient expressed desire to withdraw consent to complete PROs
* Failure to complete PROs within 24 weeks of initial invitation
* Greater than 24 months lapse of survey completion after baseline surveys completed
* Additionally, the criteria detailed for Disease Cohort apply to the Engaged Cohort
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Target PharmaSolutions, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TARGET-METABOLIC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.